Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation - PubMed (original) (raw)
Case Reports
. 1997 Mar 12;277(10):793-9.
A Ardilla, A Martínez, L Madrigal, J C Arango-Viana, C A Lemere, J C Arango-Lasprilla, L Hincapíe, M Arcos-Burgos, J E Ossa, I M Behrens, J Norton, C Lendon, A M Goate, A Ruiz-Linares, M Rosselli, K S Kosik
Affiliations
- PMID: 9052708
Case Reports
Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation
F Lopera et al. JAMA. 1997.
Abstract
Objectives: To characterize clinical features of a very large pedigree with early-onset Alzheimer disease (AD) in which all affected individuals carry the identical glutamic acid-to-alanine mutation at codon 280 in the presenilin-1 gene.
Design: Clinical histories were obtained by patient and family interviews and through medical or civil records. Using standard diagnostic criteria, a case series of 128 individuals was identified, of which 6 have definitive (autopsy-proven) early-onset AD, 93 have probable early-onset AD, and 29 have possible early-onset AD.
Setting: Community based in Antioquia, Colombia.
Patients: A population-based sample in which all members of 5 extended families (nearly 3000 individuals) were surveyed. Criteria for inclusion required obtaining sufficient information to categorize the individual as affected.
Main outcome measures: Age at onset, neuropsychological profile, neurologic history, and examination.
Results: The patients had a mean age at onset of 46.8 years (range, 34-62 years). The average interval until death was 8 years. Headache was noted in affected individuals significantly more frequently than in those not affected. The most frequent presentation was memory loss followed by behavior and personality changes and progressive loss of language ability. In the final stages, gait disturbances, seizures, and myoclonus were frequent.
Conclusions: Other than the early onset, this clinical phenotype is indistinguishable from sporadic AD except that affected individuals frequently complained of headache preceding and during the disease. Despite the uniform genetic basis for the disease, there was significant variability in the age at onset, suggesting an important role for environmental factors or genetic modifiers in determining the age at onset.
Similar articles
- Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, Lendon CL, Goate AM, McKeel DW Jr, Morris JC. Snider BJ, et al. Arch Neurol. 2005 Dec;62(12):1821-30. doi: 10.1001/archneur.62.12.1821. Arch Neurol. 2005. PMID: 16344340 - E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
Lendon CL, Martinez A, Behrens IM, Kosik KS, Madrigal L, Norton J, Neuman R, Myers A, Busfield F, Wragg M, Arcos M, Arango Viana JC, Ossa J, Ruiz A, Goate AM, Lopera F. Lendon CL, et al. Hum Mutat. 1997;10(3):186-95. doi: 10.1002/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H. Hum Mutat. 1997. PMID: 9298817 - Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene.
Axelman K, Basun H, Lannfelt L. Axelman K, et al. Arch Neurol. 1998 May;55(5):698-702. doi: 10.1001/archneur.55.5.698. Arch Neurol. 1998. PMID: 9605727 Clinical Trial. - Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
Sepulveda-Falla D, Glatzel M, Lopera F. Sepulveda-Falla D, et al. J Alzheimers Dis. 2012;32(1):1-12. doi: 10.3233/JAD-2012-120907. J Alzheimers Dis. 2012. PMID: 22766738 Review. - Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studies.
Gautrin D, Nalbantoglu J, Lacoste-Royal G, Grenon M, Gauthier S, Bouchard R, Mathieu J, Robitaille Y, Doyon LP, Bergman H, et al. Gautrin D, et al. Can J Neurol Sci. 1989 Nov;16(4 Suppl):468-72. doi: 10.1017/s0317167100029784. Can J Neurol Sci. 1989. PMID: 2680006 Review.
Cited by
- AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer's disease.
Kim YS, Choi SH, Kim KY, Navia-Pelaez JM, Perkins GA, Choi S, Kim J, Nazarenkov N, Rissman RA, Ju WK, Ellisman MH, Miller YI. Kim YS, et al. J Neuroinflammation. 2024 Sep 28;21(1):245. doi: 10.1186/s12974-024-03214-4. J Neuroinflammation. 2024. PMID: 39342323 Free PMC article. - Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City.
Sosa AL, Brucki SM, Crivelli L, Lopera FJ, Acosta DM, Acosta-Uribe J, Aguilar D, Aguilar-Navarro SG, Allegri RF, Bertolucci PH, Calandri IL, Carrillo MC, Mendez PAC, Cornejo-Olivas M, Custodio N, Damian A, de Souza LC, Duran-Aniotz C, García AM, García-Peña C, Gonzales MM, Grinberg LT, Ibanez AM, Illanes-Manrique MZ, Jack CR Jr, Leon-Salas JM, Llibre-Guerra JJ, Luna-Muñoz J, Matallana D, Miller BL, Naci L, Parra MA, Pericak-Vance M, Piña-Escudero SD, França Resende EP, Ringman JM, Sevlever G, Slachevsky A, Suemoto CK, Valcour V, Villegas-Lanau A, Yassuda MS, Mahinrad S, Sexton C. Sosa AL, et al. Alzheimers Dement. 2024 Jul;20(7):5009-5026. doi: 10.1002/alz.13850. Epub 2024 May 27. Alzheimers Dement. 2024. PMID: 38801124 Free PMC article. Review. - Modeling of age-related neurological disease: utility of zebrafish.
Kanoh T, Mizoguchi T, Tonoki A, Itoh M. Kanoh T, et al. Front Aging Neurosci. 2024 May 3;16:1399098. doi: 10.3389/fnagi.2024.1399098. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38765773 Free PMC article. Review. - Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer's disease.
Teipel S, Grazia A, Dyrba M, Grothe MJ, Pomara N. Teipel S, et al. Sci Rep. 2024 May 17;14(1):11268. doi: 10.1038/s41598-024-60799-9. Sci Rep. 2024. PMID: 38760448 Free PMC article. - Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like Neurons.
Gomez-Sequeda N, Jimenez-Del-Rio M, Velez-Pardo C. Gomez-Sequeda N, et al. Int J Mol Sci. 2024 Apr 30;25(9):4925. doi: 10.3390/ijms25094925. Int J Mol Sci. 2024. PMID: 38732141 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical